ZEB1 and primary cutaneous T-cell non-Hodgkin lymphoma: Interestingly, ZEB1 has been identified as a potent transcriptional repressor of IL‐15 and hypermethylation of its binding region in the IL‐15 promoter prevents suppression of IL‐15 production in CTCL and thus progression (Mishra et al., 2016).